2023. STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Research Focus International Scientific Journal. 2, 1 (Feb. 2023), 11–19. DOI:https://doi.org/10.66073/researchfocus.v2i1.2819.